|
Apr 4
|
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings
|
|
Apr 3
|
Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
|
|
Apr 2
|
Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch
|
|
Apr 2
|
Who Should Pay for Ozempic Is the Next Big Workplace Fight
|
|
Apr 1
|
Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform
|
|
Apr 1
|
Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback
|
|
Apr 1
|
Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform
|
|
Apr 1
|
Hims & Hers Health, Inc.'s (NYSE:HIMS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
|
|
Mar 13
|
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.
|
|
Mar 13
|
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
|
|
Mar 11
|
Define Ventures Appoints Carolyn Magill as Venture Partner
|
|
Feb 24
|
What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle
|
|
Feb 24
|
Estimating The Intrinsic Value Of Hims & Hers Health, Inc. (NYSE:HIMS)
|
|
Feb 21
|
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
|
|
Feb 21
|
Hims & Hers shares dive on end of weight loss drug shortage
|
|
Feb 21
|
CrowdStrike, Hims & Hers, Rivian: Market Minute
|
|
Feb 21
|
Hims & Hers Acquires US-based Peptide Facility
|
|
Feb 20
|
Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz
|
|
Feb 19
|
'Health insurance companies are always going to need a PBM': CVS president Prem Shah
|
|
Feb 19
|
Hims & Hers Health surges on acquisition for at-home testing
|